Clinical Definition

The Apnea-Hypopnea Index (AHI) is a diagnostic metric that quantifies the severity of sleep-disordered breathing by calculating the average number of apnea and hypopnea events per hour of sleep. An apnea is defined as a complete cessation of airflow for at least 10 seconds, while a hypopnea is a partial reduction in airflow (typically ≥30%) accompanied by either an oxygen desaturation of ≥3-4% or an arousal from sleep.

The AHI is calculated using the formula: AHI = (Total number of apneas + hypopneas) ÷ Total sleep time in hours. This index serves as the primary diagnostic criterion for obstructive sleep apnea (OSA) and is essential for treatment planning and monitoring therapeutic efficacy.

Etymology & History

The term combines "apnea" (from Greek "apnoia," meaning "without breathing") and "hypopnea" (from Greek "hypo" meaning "under" and "pnoia" meaning "breathing"). The index was formally introduced in 1988 by the American Academy of Sleep Medicine as a standardized metric.

Reference Values & Interpretation

Normal Values

  • Normal: AHI < 5 events/hour
  • Children: AHI < 1 event/hour

Abnormal Values

  • Mild OSA: AHI 5-15 events/hour
  • Moderate OSA: AHI 15-30 events/hour
  • Severe OSA: AHI > 30 events/hour

How It's Measured

AHI is measured using:

  • Polysomnography (PSG): Gold standard in-lab study.
  • Home Sleep Apnea Test (HSAT): Simplified home testing.
  • Scoring Criteria: Events must last ≥10 seconds with specific amplitude and desaturation/arousal requirements per AASM guidelines.

Role in Diagnosis

The AHI serves as the cornerstone of sleep apnea diagnosis, providing objective quantification of disease severity. Diagnostic thresholds are well-established: AHI ≥5 with symptoms or AHI ≥15 without symptoms confirms OSA diagnosis.

Role in Treatment

Treatment decisions are significantly influenced by AHI severity. Mild OSA may be managed with lifestyle modifications or oral appliances. Moderate to severe OSA typically requires CPAP therapy. Post-treatment AHI monitoring is crucial for assessing therapeutic efficacy.

Associated Conditions

rdi|odi|rera|polysomnography|hsat|osa

">

Clinical Guidelines

[{"guideline_title":"AASM Clinical Practice Guideline (2019)","guideline_link":"https://jcsm.aasm.org/doi/10.5664/jcsm.7738"}]

Latest Research & Updates

AI-Updated Weekly

Recent studies have questioned whether AHI alone adequately captures cardiovascular risk. The concept of "hypoxic burden" shows stronger correlation with cardiovascular outcomes (Azarbarzin et al., 2019).